As demonstrated in the Tsai et al. study where the adult population using eGFR based on cystatin C helped to reclassify kidney function from preserved to reduced, especially in patients with diabetes [29], this means cystatin C could be used as an earlier predictor of kidney damage compared to creatinine. This evidence concerns the gene CST3 and diabetes mellitus.